1. Home
  2. MTEX vs NCEL Comparison

MTEX vs NCEL Comparison

Compare MTEX & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mannatech Incorporated

MTEX

Mannatech Incorporated

N/A

Current Price

$6.95

Market Cap

14.0M

Sector

Health Care

ML Signal

N/A

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.45

Market Cap

13.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTEX
NCEL
Founded
1993
2008
Country
United States
Switzerland
Employees
N/A
11
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0M
13.2M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
MTEX
NCEL
Price
$6.95
$2.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.3K
16.4K
Earning Date
05-12-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
210.00
N/A
EPS
N/A
N/A
Revenue
$117,866,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.14
$1.89
52 Week High
$12.45
$4.70

Technical Indicators

Market Signals
Indicator
MTEX
NCEL
Relative Strength Index (RSI) 42.43 38.18
Support Level $6.14 $1.89
Resistance Level $7.68 $3.16
Average True Range (ATR) 0.22 0.16
MACD 0.05 -0.03
Stochastic Oscillator 36.47 10.81

Price Performance

Historical Comparison
MTEX
NCEL

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: